Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Issued (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Shares Issued for 5 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 56.07% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 56.38% decrease, with the full-year FY2025 number at $4.8 million, down 56.38% from a year prior.
  • Shares Issued was $1.6 million for Q4 2025 at PROCEPT BioRobotics, up from $1.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.0 million in Q4 2022 to a low of -$159.2 million in Q4 2023.
  • A 5-year average of -$7.6 million and a median of $1.3 million in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 4072.68% in 2023, then soared 580.53% in 2024.
  • PROCEPT BioRobotics' Shares Issued stood at -$1.8 million in 2021, then skyrocketed by 324.92% to $4.0 million in 2022, then crashed by 4072.68% to -$159.2 million in 2023, then skyrocketed by 102.26% to $3.6 million in 2024, then crashed by 56.07% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Shares Issued are $1.6 million (Q4 2025), $1.1 million (Q3 2025), and $873000.0 (Q2 2025).